New Abiraterone Acetate Mfg. Project in Medak, Telangana
A company is planning to establish a new manufacturing project in Medak, Telangana, focused on the production of Abiraterone Acetate, a critical drug used in the treatment of prostate cancer. The proposed project aims to manufacture 80 tonnes per annum of Abiraterone Acetate. This would require significant investment in research and development, manufacturing capabilities, and quality control systems. The project is currently in the planning stage, and if successful, it could benefit patients and the Indian pharmaceutical industry.
View project